The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,170.00
Bid: 4,140.00
Ask: 4,230.00
Change: 10.00 (0.24%)
Spread: 90.00 (2.174%)
Open: 4,120.00
High: 4,240.00
Low: 4,120.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
20th Feb 20139:12 amRNSDirector/PDMR Shareholding
15th Feb 201310:09 amRNSNet Asset Value(s)
14th Feb 20139:39 amRNSDirector/PDMR Shareholding
11th Feb 201312:34 pmRNSDirector/PDMR Shareholding
7th Feb 201310:02 amRNSDirector/PDMR Shareholding
6th Feb 201310:36 amRNSDirector/PDMR Shareholding
4th Feb 201312:06 pmRNSTransactions in a Close Period
10th Jan 20131:04 pmRNSNet Asset Value(s)
19th Dec 20121:11 pmRNSInterim Management Statement
13th Dec 201211:33 amRNSNet Asset Value(s)
19th Nov 20122:39 pmRNSNet Asset Value(s)
18th Oct 20129:47 amRNSDirector/PDMR Shareholding
17th Oct 20129:46 amRNSNet Asset Value(s)
11th Oct 20123:37 pmRNSDirector/PDMR Shareholding
10th Oct 201210:05 amRNSDirector/PDMR Shareholding
4th Oct 20129:59 amRNSDirector/PDMR Shareholding
1st Oct 201212:21 pmRNSDirector/PDMR Shareholding
19th Sep 20129:01 amRNSHalf Yearly Report
13th Sep 201210:55 amRNSHolding(s) in Company
11th Sep 20121:07 pmRNSHalf Yearly Report
11th Sep 20129:50 amRNSNet Asset Value(s)
10th Sep 201212:39 pmRNSDirector/PDMR Shareholding
6th Sep 20122:21 pmRNSDirector/PDMR Shareholding
17th Aug 20128:02 amRNSDirector/PDMR Shareholding
16th Aug 201210:38 amRNSDirector/PDMR Shareholding
14th Aug 20129:45 amRNSDirector/PDMR Shareholding
14th Aug 20129:43 amRNSNet Asset Value(s)
13th Aug 201212:26 pmRNSListing Rule 15.5.1(4)
13th Aug 201211:22 amRNSDirector/PDMR Shareholding
9th Jul 20123:43 pmRNSNet Asset Value(s)
9th Jul 201210:54 amRNSAdditional Listing
29th Jun 20129:45 amRNSChange of Adviser
27th Jun 20123:03 pmRNSDirector/PDMR Shareholding
27th Jun 20122:13 pmRNSResult of AGM
26th Jun 20128:50 amRNSDirector/PDMR Shareholding
25th Jun 201210:03 amRNSDirector/PDMR Shareholding
20th Jun 20129:20 amRNSDirector/PDMR Shareholding
19th Jun 20122:43 pmRNSInterim Management Statement
18th Jun 20129:54 amRNSNet Asset Value(s)
13th Jun 20127:00 amRNSDirector/PDMR Shareholding
12th Jun 201210:43 amRNSDirector/PDMR Shareholding
7th Jun 20129:41 amRNSDirector/PDMR Shareholding
1st Jun 20128:40 amRNSDirector/PDMR Shareholding
31st May 20129:58 amRNSDoc re. Annual Report
28th May 20129:23 amRNSDirector/PDMR Shareholding
24th May 20126:18 pmRNSDirector/PDMR Shareholding
23rd May 20126:22 pmRNSFinal Results
21st May 201210:46 amRNSDirector/PDMR Shareholding
16th May 20129:24 amRNSNet Asset Value(s)
15th May 20123:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.